⌘K
Loading ticker…
Rein Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rein Therapeutics, Inc. Common Stock (RNTX) has a 3-month relative strength percentile of 14 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.8%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
14 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
RNTX is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.3% / -23.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RNTX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $955K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $955K |
| VXFVanguard Extended Market ETF | 0.00% | $343K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RNTX Jan avg: 7.07% median: 7.07% win: 100% σ: 7.07% n: 2 2025-01-14 → 2026-05-29 | RNTX Feb avg: -3.11% median: -3.11% win: 50% σ: 13.01% n: 2 2025-01-14 → 2026-05-29 | RNTX Mar avg: -0.64% median: -0.64% win: 50% σ: 20.75% n: 2 2025-01-14 → 2026-05-29 | RNTX Apr avg: 0.42% median: 0.42% win: 50% σ: 5.39% n: 2 2025-01-14 → 2026-05-29 | RNTX May avg: -2.02% median: -2.02% win: 50% σ: 22.71% n: 2 2025-01-14 → 2026-05-29 | RNTX Jun avg: -28.21% median: -28.21% win: 0% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 (current) | RNTX Jul avg: -16.79% median: -16.79% win: 0% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 | RNTX Aug avg: 19.31% median: 19.31% win: 100% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 | RNTX Sep avg: -17.63% median: -17.63% win: 0% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 | RNTX Oct avg: 36.68% median: 36.68% win: 100% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 | RNTX Nov avg: 0.32% median: 0.32% win: 100% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 | RNTX Dec avg: -26.11% median: -26.11% win: 0% σ: 0.00% n: 1 2025-01-14 → 2026-05-29 |